Arteriotomy closure devices for cardiovascular procedures: A scientific statement from the american heart association

Circulation

Volumn 122, Issue 18, 2010, Pages 1882-1893

  Patel, Manesh R ^a   Jneid, Hani ^a   Derdeyn, Colin P ^a   Klein, Lloyd W ^a   Levine, Glenn N ^a   Lookstein, Robert A ^a   White, Christopher J ^a   Yeghiazarians, Yerem ^a   Rosenfield, Kenneth ^a  

^a NONE

Author keywords

AHA Scientific Statements; catheterization; collagen; hemostasis; vascular closure

Indexed keywords

COLLAGEN;

ARTERIOTOMY; ARTERIOTOMY CLOSURE DEVICE; ARTERIOVENOUS FISTULA; ARTERY PUNCTURE; CARDIOVASCULAR PROCEDURES; CLIP; COMPRESSION; FALSE ANEURYSM; FEMORAL ANGIOGRAPHY; FEMORAL ARTERY; HEART CATHETERIZATION; HEMOSTASIS; HIGH RISK POPULATION; HUMAN; INFECTION; MANUAL COMPRESSION; PATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROPERITONEAL HEMATOMA; REVIEW; SUTURE; SYSTEMATIC REVIEW; VASCULAR ACCESS DEVICE;

AMERICAN HEART ASSOCIATION; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SURGICAL PROCEDURES; EQUIPMENT AND SUPPLIES; HUMANS; RISK FACTORS; UNITED STATES; WOUND CLOSURE TECHNIQUES;

EID: 78349309701     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0b013e3181f9b345     Document Type: Review

References (65)

1. Seldinger SI. Catheter replacement of the needle in percutaneous arte-riography: a new technique. Acta Radiol. 1953;39:368-376.
2. Meyerson SL, Feldman T, Desai TR, Leef J, Schwartz LB, McKinsey JF. Angiographic access site complications in the era of arterial closure devices. VascEndovascularSurg. 2002;36:137-144.
3. 2008 Global Vascular Closure Device Markets: US, Europe, Rest of World. Huntington Beach, Calif: Life Science Intelligence 2008.
4. Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. Am Heart J. 2009;157:132-140.
5. Kiemeneij F, Laarman GJ, Odekerken D, Slagboom T, van der Wieken R. A randomized comparison of percutaneous transluminal coronary angio-plasty by the radial, brachial and femoral approaches: the access study. J Am Coll Cardiol. 1997;29:1269-1275
6. Rao SV, Ou FS, Wang TY, Roe MT, Brindis R, Rumsfeld JS, Peterson ED. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. JACC Cardiovasc Interv. 2008; 1:379-386.
7. Sherev DA, Shaw RE, Brent BN. Angiographic predictors of femoral access site complications: implication for planned percutaneous coronary intervention. Catheter Cardiovasc Interv. 2005;65:196-202.
8. Tavris DR, Gallauresi BA, Lin B, Rich SE, Shaw RE, Weintraub WS, Brindis RG, Hewitt K. Risk of local adverse events following cardiac catheterization by hemostasis device use and gender. J Invasive Cardiol. 2004;16:459-464.
9. Nasser TK, Mohler ER 3rd, Wilensky RL, Hathaway DR. Peripheral vascular complications following coronary interventional procedures. Clin Cardiol. 1995;18:609-614.
10. Pepine CJ, Allen HD, Bashore TM, Brinker JA, Cohn LH, Dillon JC, Hillis LD, Klocke FJ, Parmley WW, Ports TA. ACC/AHA guidelines for cardiac catheterization and cardiac catheterization laboratories: American College of Cardiology/American Heart Association Ad Hoc Task Force on Cardiac Catheterization. Circulation. 1991;84:2213-2247.
11. Koreny M, Riedmüller E, NikfardJ Am M, Siostrzonek P, Müllner M. Arterial puncture closing devices compared with standard manual com-pression after cardiac catheterization: systematic review and meta-anal-ysis. JAMA. 2004;291:350-357.
12. Piper WD, Malenka DJ, Ryan TJ Jr, Shubrooks SJ Jr, O'Connor GT, Robb JF, Farrell KL, Corliss MS, Hearne MJ, Kellett MA Jr, Watkins MW, Bradley WA, Hettleman BD, Silver TM, McGrath PD, O'Mears JR, Wennberg DE; Northern New England Cardiovascular Disease Study Group. Predicting vascular complications in percutaneous coronary inter-ventions. Am Heart J. 2003;145:1022-1029.
13. Nikolsky E, Mehran R, Halkin A, Aymong ED, Mintz GS, Lasic Z, Negoita M, Fahy M, Krieger S, Moussa I, Moses JW, Stone GW, Leon MB, Pocock SJ, Dangas G. Vascular complications associated with arte-riotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol. 2004;44:1200-1209.
14. Bashore TM, Bates ER, Berger PB, Clark DA, Cusma JT, Dehmer GJ, Kern MJ, Laskey WK, O'Laughlin MP, Oesterle S, Popma JJ, O'Rourke RA, Abrams J, Bates ER, Brodie BR, Douglas PS, Gregoratos G, Hlatky MA, Hochman JS, Kaul S, Tracy CM, Waters DD, Winters WL Jr. American College of Cardiology/Society for Cardiac Angiography and Interventions clinical expert consensus document on cardiac catheteriza-tion laboratory standards: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2001;37:2170-2214.
15. Konstance R, Tcheng JE, Wightman MB, Kelly LP, Moore A, Harrison JK, Sketch MH Jr. Incidence and predictors of major vascular compli-cations after percutaneous coronary intervention in the glycoprotein IIb/IIIa platelet inhibitor era. J Interv Cardiol. 2004;17:65-70.
16. Arora N, Matheny ME, Sepke C, Resnic FS. A propensity analysis of the risk of vascular complications after cardiac catheterization procedures withtheuse of vascular closure devices. Am Heart J. 2007;153:606-611.
17. Hermiller JB, Simonton C, Hinohara T, Lee D, Cannon L, Mooney M, O'Shaughnessy C, Carlson H, Fortuna R, Zapien M, Fletcher DR, DiDonato K, Chou TM. The Star Close Vascular Closure System: inter-ventional results from the CLIP study. Catheter Cardiovasc Interv. 2006; 68:677-683.
18. Dangas G, Mehran R, Kokolis S, Feldman D, Satler LF, Pichard AD, Kent KM, Lansky AJ, Stone GW, Leon MB. Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol. 2001;38:638-641.
19. Applegate RJ, Grabarczyk MA, Little WC, Craven T, Walkup M, Kahl FR, Braden GA, Rankin KM, Kutcher MA. Vascular closure devices in patients treated with anticoagulation and IIb/IIIa receptor inhibitors during percutaneous revascularization. J Am Coll Cardiol. 2002;40: 78-83.
20. Rajdev S, Krishnan P, Irani A, Kim MC, Moreno PR, Sharma SK, Kini AS. Clinical application of prophylactic percutaneous left ventricular assist device (TandemHeart) in high-risk percutaneous coronary inter-vention using an arterial preclosure technique: single-center experience. J Invasive Cardiol. 2008;20:67-72.
21. Shim CY, Park S, Ko YG, Choi D, Jang Y, Shim WH. Percutaneous closure of femoral artery access sites in endovascular stent-graft treatment of aortic disease. Int J Cardiol. 2008;130:251-254.
22. Kahlert P, Eggebrecht H, Erbel R, Sack S. A modified " preclosure" technique after percutaneous aortic valve replacement. Catheter Cardiovasc Interv. 2008;72:877-884.
23. Lee WA, Brown MP, Nelson PR, Huber TS, Seeger JM. Midterm outcomes of femoral arteries after percutaneous endovascular aortic repair using the Preclose technique. J Vasc Surg. 2008;47:919-923.
24. Korngold EC, Inglessis I, Garasic JM. A novel technique for 14 French arteriotomy closure after percutaneous aortic valvuloplasty using two Mynx closure devices. J Interv Cardiol. 2009;22:179-183.
25. Kussmaul WG 3rd, Buchbinder M, Whitlow PL, Aker UT, Heuser RR, King SB, Kent KM, Leon MB, Kolansky DM, Sandza JG Jr. Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty: results of a randomized trial of a novel hemostatic device. J Am Coll Cardiol. 1995;25:1685-1692.
26. Chevalier B, Lancelin B, Koning R, Henry M, Gommeaux A, Pilliere R, Elbaz M, Lefevre T, Boughalem K, Marco J, Dupouy P; HEMOSTASE Trial Investigators. Effect of a closure device on complication rates in high-local-risk patients: results of a randomized multicenter trial. Catheter Cardiovasc Interv. 2003;58:285-291.
27. Ward SR, Casale P, Raymond R, Kussmaul WG 3rd, Simpfendorfer C; Angio-Seal Investigators. Efficacy and safety of a hemostatic puncture closure device with early ambulation after coronary angiography. Am J Cardiol. 1998;81:569-572.
28. Amin FR, Yousufuddin M, Stables R, Shamim W, Al-Nasser F, Coats AJ, Clague J, Sigwart U. Femoral haemostasis after transcatheter therapeutic intervention: a prospective randomised study of the Angio-Seal device vs. the FemoStop device. Int J Cardiol. 2000;76:235-240.
29. Gerckens U, Cattelaens N, Lampe EG, Grube E. Management of arterial puncture site after catheterization procedures: evaluating a suture-mediated closure device. Am J Cardiol. 1999;83:1658-1663.
30. Baim DS, Knopf WD, Hinohara T, Schwarten DE, Schatz RA, Pinkerton CA, Cutlip DE, Fitzpatrick M, Ho KK, Kuntz RE. Suture-mediated closure of the femoral access site after cardiac catheterization: results of the Suture To Ambulate aNd Discharge (STAND I and STAND II) trials. Am J Cardiol. 2000;85:864-869.
31. Carere RG, Webb JG, Buller CE, Wilson M, Rahman T, Spinelli J, Anis AH. Suture closure of femoral arterial puncture sites after coronary angioplasty followed by same-day discharge. Am Heart J. 2000;139(pt 1):52-58.
32. Noguchi T, Miyazaki S, Yasuda S, Baba T, Sumida H, Morii I, Daikoku S, Goto Y, Nonogi H. A randomised controlled trial of Prostar Plus for haemostasis in patients after coronary angioplasty. Eur J Vasc Endovasc Surg. 2000;19:451-455.
33. Wetter DR, Rickli H, von Smekal A, Amann FW. Early sheath removal after coronary artery interventions with use of a suture-mediated closure device: clinical outcome and results of Doppler US evaluation. J Vasc Interv Radiol. 2000;11:1033-1037.
34. Rickli H, Unterweger M, Sütsch G, Brunner-La Rocca HP, Sagmeister M, Ammann P, Amann FW. Comparison of costs and safety of a suture-mediated closure device with conventional manual compression after coronary artery interventions. Catheter Cardiovasc Interv. 2002;57: 297-302.
35. Nasu K, Tsuchikane E, Sumitsuji S; PARADISE Investigators. Clinical effectiveness of the Prostar XL suture-mediated percutaneous vascular closure device following PCI: results of the Perclose AcceleRated Ambu-lation and DISchargE (PARADISE) Trial. J Invasive Cardiol. 2003;15: 251-256.
36. Hermiller J, Simonton C, Hinohara T, Lee D, Cannon L, Mooney M, O'Shaughnessy C, Carlson H, Fortuna R, Yarbrough CA, Zapien M, Chou T. Clinical experience with a circumferential clip-based vascular closure device in diagnostic catheterization. J Invasive Cardiol. 2005;17: 504-510.
37. Jaff MR, Hadley G, Hermiller JB, Simonton C, Hinohara T, Cannon L, Reisman M, Braden G, Fletcher DR, Zapien M, Chou TM, DiDonato K. The safety and efficacy of the Star Close Vascular Closure System: the ultrasound substudy of the CLIP study. Catheter Cardiovasc Interv. 2006;68:684-689.
38. Veasey RA, Large JK, Silberbauer J, Paul G, Taggu W, Ellery S, Rathore VS, Lloyd GW, Patel NR, Sulke AN. A randomised controlled trial comparing Star Close and AngioSeal vascular closure devices in a district general hospital: the SCOAST study. Int J Clin Pract. 2008;62:912-918.
39. Sridhar K, Fischman D, Goldberg S, Zalewski A, Walinsky P, Porter D, Fenton S, Gupta B, Rake R, Gebhardt S, Savage M. Peripheral vascular complications after intracoronary stent placement: prevention by use of a pneumatic vascular compression device. Cathet Cardiovasc Diagn. 1996; 39:224-229.
40. Jaspers L, Benit E. Immediate sheath removal after PCI using a Femostop is feasible and safe: results of a registry. Acta Cardiol. 2003;58:535-537.
41. Rudisill PT, Williams LB, Craig S, Schopp P. Study ofmechanical versus manual/mechanical compression following various interventional cardi-ology procedures. J Cardiovasc Nurs. 1997;11:15-21.
42. Walker SB, Cleary S, Higgins M. Comparison of the FemoStop device and manual pressure in reducing groin puncture site complications fol-lowing coronary angioplasty and coronary stent placement. Int J Nurs Pract. 2001;7:366-375.
43. Doyle BJ, Godfrey MJ, Lennon RJ, Ryan JL, Bresnahan JF, Rihal CS, Ting HH. Initial experience with the Cardiva Boomerang vascular closure device in diagnostic catheterization. Catheter Cardiovasc Interv. 2007; 69:203-208.
44. Scheinert D, Sievert H, Turco MA, Schmidt A, Hauptmann KE, Mueller R, Dadourian D, Krankenberg H, Grube E. The safety and efficacy of an extravascular, water-soluble sealant for vascular closure: initial clinical results for Mynx [published correction appears in Catheter Cardiovasc Interv. 2008;71:129]. Catheter Cardiovasc Interv. 2007;70:627-633.
45. Nguyen N, Hasan S, Caufield L, Ling FS, Narins CR. Randomized controlled trial of topical hemostasis pad use for achieving vascular hemostasis fol-lowing percutaneous coronary intervention. Catheter Cardiovasc Interv. 2007;69:801-807.
46. Nader RG, Garcia JC, Drushal K, Pesek T. Clinical evaluation of SyvekPatch in patients undergoing interventional, EPS and diagnostic cardiac catheterization procedures. J Invasive Cardiol. 2002;14:305-307.
47. Hallak OK, Cubeddu RJ, Griffith RA, Reyes BJ. The use of the D-STAT dry bandage for the control of vascular access site bleeding: a multicenter experience in 376 patients. Cardiovasc Intervent Radiol. 2007;30: 593-600.
48. Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Kahl FR, Little WC. Propensity score analysis of vascular compli-cations after diagnostic cardiac catheterization and percutaneous coronary intervention using thrombin hemostatic patch-facilitated manual com-pression. J Invasive Cardiol. 2007;19:164-170.
49. Rastan A, Sixt S, Schwarzwälder U, Schwarz T, Frank U, Bürgelin K, Pochert V, Noory E, Amantea P, Gremmelmaier D, Müller C, Büttner HJ, Neumann FJ, Zeller T. VIPER-2: a prospective, randomized single-center comparison of 2 different closure devices with a hemostatic wound dressing for closure of femoral artery access sites. J Endovasc Ther. 2008;15:83-90.
50. Schräder R, Steinbacher S, Burger W, Kadel C, Vallbracht C, Kaltenbach M. Collagen application for sealing of arterial puncture sites in com-parison to pressure dressing: a randomized trial. Cathet Cardiovasc Diagn. 1992;27:298-302.
51. Ansel G, Yakubov S, Neilsen C, Allie D, Stoler R, Hall P, Fail P, Sanborn T, Caputo RP. Safety and efficacy of staple-mediated femoral arteriotomy closure: results from a randomized multicenter study. Catheter Cardiovasc Interv. 2006;67:546-553.
52. Slaughter PM, Chetty R, Flintoft VF, Lewis S, Sykora K, Beattie DM, Schwartz L. A single center randomized trial assessing use of a vascular hemostasis device vs. conventional manual compression following PTCA: what are the potential resource savings? Cathet Cardiovasc Diagn. 1995;34:210-214.
53. Sanborn TA, Gibbs HH, Brinker JA, Knopf WD, Kosinski EJ, Roubin GS. A multicenter randomized trial comparing a percutaneous collagen hemostasis device withconventional manual compression after diagnostic angiography and angioplasty. J Am Coll Cardiol. 1993;22:1273-1279.
54. Silber S, Björvik A, Mühling H, Rösch A. Usefulness of collagen plugging with VasoSeal after PTCA as compared to manual compression with identical sheath dwell times. Cathet Cardiovasc Diagn. 1998;43: 421-427.
55. Camenzind E, Grossholz M, Urban P, Dorsaz PA, Didier D, Meier B. Collagen application versus manual compression: a prospective ran-domized trial for arterial puncture site closure after coronary angioplasty. J Am Coll Cardiol. 1994;24:655-662.
56. von Hoch F, Neumann FJ, Theiss W, Kastrati A, Schömig A. Efficacy and safety of collagen implants for haemostasis of the vascular access site after coronary balloon angioplasty and coronary stent implantation: a randomized study. Eur Heart J. 1995;16:640-646.
57. Chamberlin JR, Lardi AB, McKeever LS, Wang MH, Ramadurai G, Grunenwald P, Towne WP, Grassman ED, Leya FS, Lewis BE, Stein LH. Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring abciximab (ReoPro). Catheter Cardiovasc Interv. 1999;47: 143-147.
58. Sesana M, Vaghetti M, Albiero R, Corvaja N, Martini G, Sivieri G, Colombo A. Effectiveness and complications of vascular access closure devices after interventional procedures. J Invasive Cardiol. 2000;12: 395-399.
59. Duffin DC, Muhlestein JB, Allisson SB, Horne BD, Fowles RE, Sorensen SG, Revenaugh JR, Bair TL, Lappe DL. Femoral arterial puncture man-agement after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices. J Invasive Cardiol. 2001;13:354-362.
60. Assali AR, Sdringola S, Moustapha A, Ghani M, Salloum J, Schroth G, Fujise K, Anderson HV, Smalling RW, Rosales OR. Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices. Catheter Cardiovasc Interv. 2003;58:1-5.
61. Vaitkus PT. A meta-analysis of percutaneous vascular closure devices after diagnostic catheterization and percutaneous coronary intervention. J Invasive Cardiol. 2004;16:243-246.
62. Dauerman HL, Applegate RJ, Cohen DJ. Vascular closure devices: the second decade. J Am Coll Cardiol. 2007;50:1617-1626.
63. Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Little WC. Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention 1998-2003. Catheter Cardiovasc Interv. 2006;67:556-562.
64. Heyde GS, Koch KT, de Winter RJ, Dijkgraaf MG, Klees MI, Dijksman LM, Piek JJ, Tijssen JG. Randomized trial comparing same-day discharge with overnight hospital stay after percutaneous coronary intervention: results of the Elective PCI in Outpatient Study (EPOS). Circulation. 2007;115:2299-2306.
65. Doyle BJ, Konz BA, Lennon RJ, Bresnahan JF, Rihal CS, Ting HH. Ambulation 1 hour after diagnostic cardiac catheterization: aprospective study of 1009 procedures. Mayo Clin Proc. 2006;81:1537-1540.